close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar929397Point02
Implied share price

Buy Undervalued by 1218781.3%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AMGN
Amgen, Inc.
Change
294474.73 23.69 392789.88 8.93 8.17 14.36
All amounts in millions
from last financial year
         
Implied Share Price $929397.02 $46835.02 $3186189.05 $2022094.68 $3360492.17
Market Cap 18,291 1,229,412 156,540 133,296 120,636
Net Debt -371 20 -11,726 7,473 3,689
Enterprise Value (EV) 18,961 1,229,432 144,814 73,616 124,325
Revenue 4,048 44 24,890 34,109 20,063
EBITDA 800 3 16,219 9,010 8,660
Percent 19.8 % 7.1 % 65.2 % 26.4 % 43.2 %
EBIT 332 1 15,383 6,528 6,568
Percent 8.2 % 3.6 % 61.8 % 19.1 % 32.7 %
Balance Sheet          
Total Assets 10,913 58 34,664 97,392 69,009
Total Liabilities 3,326 56 18,830 41,272 43,231
Shareholders Equity 7,586 2 15,834 56,120 25,778.0

Comments

No comments yet. Login to comment.